Literature DB >> 10329125

Cyclin T1 domains involved in complex formation with Tat and TAR RNA are critical for tat-activation.

D Ivanov1, Y T Kwak, E Nee, J Guo, L F García-Martínez, R B Gaynor.   

Abstract

Tat activates transcription from the human immunodeficiency virus type 1 (HIV-1) long terminal repeat (LTR) by increasing the processivity of RNA polymerase II. Recently, it has been demonstrated that the cellular kinase CDK9 and its binding partner cyclin T1 are involved in regulating transcriptional elongation and tat-activation. Cyclin T1, CDK9 and Tat bind as a complex to elements in TAR RNA that are required for tat-activation. Here, we used cyclin T1 mutants to define domains in this protein that bind to both CDK9 and Tat and are involved in stimulating tat-activation. The region of cyclin T1 extending from amino acid residues 1 to 263 is necessary for complex formation with Tat bound to TAR RNA and for stimulation of tat-activation in murine cells that are normally poorly responsive to the actions of Tat. In contrast, a smaller region of cyclin T1 was required to bind to CDK9 and stimulate its kinase activity. Recombinant cyclin T1 and CDK9 stimulated both basal and tat-induced in vitro transcriptional elongation from the HIV-1 LTR. The effects of Tat on transcriptional elongation may be mediated by its ability to increase CDK9 phosphorylation of the RNA polymerase II C-terminal domain. These results demonstrate that cyclin T1 interactions with Tat and TAR RNA are critical for activation of HIV-1 gene expression. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10329125     DOI: 10.1006/jmbi.1999.2663

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  38 in total

1.  Spt5 cooperates with human immunodeficiency virus type 1 Tat by preventing premature RNA release at terminator sequences.

Authors:  Cyril F Bourgeois; Young Kyeung Kim; Mark J Churcher; Michelle J West; Jonathan Karn
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

2.  Interaction between P-TEFb and the C-terminal domain of RNA polymerase II activates transcriptional elongation from sites upstream or downstream of target genes.

Authors:  Ran Taube; Xin Lin; Dan Irwin; Koh Fujinaga; B Matija Peterlin
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

3.  TAR RNA loop: a scaffold for the assembly of a regulatory switch in HIV replication.

Authors:  Sara Richter; Yueh-Hsin Ping; Tariq M Rana
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-04       Impact factor: 11.205

4.  Selection of TAR RNA-binding chameleon peptides by using a retroviral replication system.

Authors:  Baode Xie; Valerie Calabro; Mark A Wainberg; Alan D Frankel
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

Review 5.  Comparative pathogenesis of epsilonretroviruses.

Authors:  Donald Holzschu; Lorie A Lapierre; Michael D Lairmore
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

6.  Closing loop base pairs in RNA loop-loop complexes: structural behavior, interaction energy and solvation analysis through molecular dynamics simulations.

Authors:  Jérôme Golebiowski; Serge Antonczak; Juan Fernandez-Carmona; Roger Condom; Daniel Cabrol-Bass
Journal:  J Mol Model       Date:  2004-10-22       Impact factor: 1.810

7.  Liquid-crystal NMR structure of HIV TAR RNA bound to its SELEX RNA aptamer reveals the origins of the high stability of the complex.

Authors:  Hélène Van Melckebeke; Matthew Devany; Carmelo Di Primo; François Beaurain; Jean-Jacques Toulmé; David L Bryce; Jérôme Boisbouvier
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-07       Impact factor: 11.205

8.  Differential acetylation of Tat coordinates its interaction with the co-activators cyclin T1 and PCAF.

Authors:  Vanessa Brès; Hideaki Tagami; Jean-Marie Péloponèse; Erwan Loret; Kuan-Teh Jeang; Yoshihiro Nakatani; Stephane Emiliani; Monsef Benkirane; Rosemary E Kiernan
Journal:  EMBO J       Date:  2002-12-16       Impact factor: 11.598

9.  Antiapoptotic function of Cdk9 (TAK/P-TEFb) in U937 promonocytic cells.

Authors:  S M Foskett; R Ghose; D N Tang; D E Lewis; A P Rice
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

10.  Recruitment of cdk9 to the immediate-early viral transcriptosomes during human cytomegalovirus infection requires efficient binding to cyclin T1, a threshold level of IE2 86, and active transcription.

Authors:  Anokhi J Kapasi; Charles L Clark; Karen Tran; Deborah H Spector
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.